In a new study researchers found that people receiving Wegovy (semaglutide) lost an average of 10% of their body weight after four years. An earlier analysis of data from this trial found that semaglutide reduced the risk of heart attack, stroke and cardiovascular death in people with obesity or who are overweight.
Healthline Multiple Sclerosis
August 19, 2025
People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later
 
READ ON
→
How Miss America Madison Marsh Is Working to Improve Cancer Care
 
READ ON
→
Wegovy Helped This Dad of 3 Lose 50 Pounds. Here’s How He’s Keeping It Off
 
READ ON
→
Financial Resources for Managing COPD
 
READ ON
→
MORE STORIES
RESOURCE FOR YOU
 
 
 
COPD CARE TEAM BUILDER
Overall health
 
Lung health
Breathing difficulties
 
Surgery for COPD
Quitting smoking
 
Diet or nutrition
HEALTHLINE RESOURCE
 
What we’re reading next
The Best Protein Powders for Men in 2025
How to Replace Doomscrolling with Hopescrolling
How to Identify and Treat Chlamydia During Pregnancy
What Is the Best Type of Protein for Weight Loss?
 
healthline
FB   Tiktok   TW   youtube   INSTA